Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 9, 2001, Pages 1675-1681

  Pack, Allan I ^a   Black, Jed E ^b   Schwartz, Jonathan R L ^b   Matheson, Jean K ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Modafinil; Obstructive; Positive pressure respiration; Sleep apnea; Wakefulness

Indexed keywords

MODAFINIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP APNEA SYNDROME; SOMNOLENCE;

EID: 0035509118     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.9.2103032     Document Type: Article

References (68)

1. The occurrence of sleep-disordered breathing among middle-aged adults
2. Severe obstructive sleep apnea-II: Associated psychopathology and psychosocial consequences
3. Association of sleep apnoea with myocardial infarction in men
4. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients
5. Cardiopulmonary consequences of obstructive sleep apnea
6. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients
7. Mortality in sleep apnea patients: A multivariate analysis of risk factors
8. Increased mortality among sleepy snorers: A prospective population based study
9. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study
10. Prospective study of the association between sleep-disordered breathing and hypertension
11. Sleep-disordered breathing and occupational accidents
12. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults
13. The association between sleep apnea and the risk of traffic accidents
14. Automobile accidents in patients with sleep apnea syndrome
15. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep
16. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients. A consensus statement
17. Obstructive sleep apnea
18. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised prospective parallel trial
19. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome
20. Measuring health related quality of life in sleep apnea
21. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome
22. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy
23. Predictors of improvements in daytime function outcomes with CPAP therapy
24. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome
25. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea
26. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP)
27. Recovery of alertness after CPCP in apnea
28. Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome
29. Is more NCPAP better?
30. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment)
31. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
32. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
33. A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy
34. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
35. Long-term efficacy and safety of modafinil (PROVIGIL®) for the treatment of excessive daytime sleepiness associated with narcolepsy
36. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
37. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance
38. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. Effects on two nights of recovery sleep
39. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining alertness and performance of aviators: A helicopter simulation study
40. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy
41. Self-monitoring cognitive performance during sleep deprivation: Effects of modafinil, d-amphetamine and placebo
42. Modafinil in obstructive sleep apnea-hypopnea syndrome: A pilot study in 6 patients
43. Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea?
44. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
45. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea
46. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness
47. Frequency of EEG arousals from nocturnal sleep in normal subjects
48. Movement arousals and sleep-related disordered breathing in adults
49. Nasal continuous positive airway pressure treatment: Current realities and future
50. Relationship between sleepiness and general health status
51. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: Failure of the MSLT as a gold standard
52. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure
53. Group education sessions and compliance with nasal CPAP therapy
54. Neurobehavioral consequences of arousals
55. Interobserver variability in recognizing arousal in respiratory sleep disorders
56. Variation in the arousal pattern after obstructive events in obstructive sleep apnea
57. Night-to-night arousal variability and interscorer reliability of arousal measurements
58. What is hypopnea, anyway?
59. A comparison of apnea-hypopnea indices derived from different definitions of hypopnea
60. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome
61. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?
62. Development of nocturnal respiratory disturbance in untreated patients with obstructive sleep apnea syndrome
63. Natural evolution of moderate sleep apnoea syndrome: Significant progression over a mean of 17 months
64. Sleep apnea and hypertension: A population-based study
65. Population-based study of sleep-disordered breathing as a risk factor for hypertension